Open AccessProspective study of bethesda categories III and IV thyroid nodules: Outcomes and predictive value of BRAFV600E mutation
Author(s) -
Shiga Rappai Chirayath,
Praveen V Pavithran,
Nithya Abraham,
Vasantha Nair,
Nisha Bhavani,
Harish Kumar,
Usha Me,
Arun S Me
Publication year - 2019
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_635_18
Subject(s) - medicine , thyroid nodules , malignancy , indeterminate , atypia , prospective cohort study , bethesda system , thyroid , cytology , cytopathology , radiology , nodule (geology) , gynecology , pathology , paleontology , mathematics , pure mathematics , biology
Atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has emerged as the most controversial category because of its heterogeneity and inconsistent reporting. There is a definite paucity in data available from the Indian subcontinent about the outcome of nodules carrying Bethesda category III or Bethesda category IV diagnoses.